参考文献
2. Robichaux, JP, Elamin, YY, Tan, Z, et,al. Mechanisms and clinical activity of an EGFR and HER2 exon 20 selective kinase inhibitor in non-small cell lung cancer. Nat med, 2018
3. Yasuda, H, et al. Structural, biochemical and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer. Sci Transl Med, 2013
4. Yasuda, H, Kobayashi S, Costa D. EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications. Lancet oncol, 2012